Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Advances in Therapy|March 8, 2023
Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical PerspectiveMasakazu Abe, Hirotoshi Iihara, Kenjiro AogiAsia-Pacific Journal of Oncology Nursing|January 10, 2024
The role of pharmacists in multimodal cancer cachexia careHironori Fujii, Yunami Yamada, Hirotoshi Iihara, et al.Anticancer Research|March 4, 2025
Anamorelin in the Management of Cancer Cachexia: Clinical Efficacy, Challenges, and Future DirectionsHironori Fujii, Yunami Yamada, Hirotoshi Iihara, et al.The Oncologist|April 15, 2022
One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysisDaichi Watanabe, Hirotoshi Iihara, Hironori Fujii, et al.Journal of Pharmaceutical Policy and Practice|January 17, 2023
A pharmacist check of patients' infection-related condition prior to drug preparation reduces anticancer drug wastage after mixing: a retrospective studyHirotsugu Yamada, Yuto Yamada, Hirotoshi Iihara, et al.Journal of Clinical Microbiology|August 6, 2005
Corynebacterium resistens sp. nov., a new multidrug-resistant coryneform bacterium isolated from human infectionsYoshihito Otsuka, Yoshiaki Kawamura, Takashi Koyama, et al.Anticancer Research|December 11, 2013
Improvement of adherence to guidelines for antiemetic medication enhances emetic control in patients with colorectal cancer receiving chemotherapy of moderate emetic riskHironori Fujii, Hirotoshi Iihara, Masashi Ishihara, et al.Anticancer Research|December 7, 2016
Control of Nausea and Vomiting in Patients with Colorectal Cancer Receiving Chemotherapy with Moderate Emetic RiskAkio Suzuki, Ryo Kobayashi, Hironori Fujii, et al.Cancer Science|December 4, 2020
5HT3 RA plus dexamethasone plus aprepitant for controlling delayed chemotherapy-induced nausea and vomiting in colorectal cancerToshinobu Hayashi, Mototsugu Shimokawa, Koichi Matsuo, et al.The Oncologist|February 12, 2020
A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in JapanHirotoshi Iihara, Mototsugu Shimokawa, Toshinobu Hayashi, et al.Pageof 12